North America Cluster Headache Market Size, Share & Industry Trends Analysis Report By Distribution channel, By Type, By Drug Class, By Country and Growth Forecast, 2022

List of Tables

The North America Cluster Headache Market would witness market growth of 3.3% CAGR during the forecast period (2022-2028).

Cluster headaches are known to frequently strike at the same hour every day. For instance, people often get headaches in the morning after sleeping for a few hours. People frequently get cluster headaches yearly for several years, which might last a lifetime. They often occur in the spring and fall, and they tend to occur at comparable periods of the year. Typically, if a brain scan for cluster headaches is expected, the diagnosis may be determined based only on patient symptoms without the need for additional testing.

To discuss the treatment choices after receiving a diagnosis of cluster headaches, patients would often consult a specialist, such as a neurologist (a doctor specializing in diseases of the brain and nervous system). The way cluster headaches impact patients give them their name. Most people first appear in clusters or groups before passing briefly. Although some headaches are shorter and others longer, they typically last 30 to 45 minutes each.

Throughout 24 hours, people can have up to eight of these headaches. And this might continue like this for days, weeks or even months. The clusters typically halt after that for unknown reasons. For months or years, the headaches go into remission before coming back. Nonetheless, some people never seem to have any fortune. They regularly (ongoingly) suffer from cluster headaches. One in five persons who suffer from cluster headaches experiences this.

One of Canada's most creative sectors is the pharmaceutical one. It is made up of businesses that create and produce new pharmaceuticals, generic medications, and over-the-counter medication goods. The industry is divided into several subsectors that cater to various industry segments. They consist of name-brand medicines, generic medications, small and medium-sized biopharmaceutical businesses (SMEs), contract research organizations (CROs), and contract manufacturing companies (CMOs). Canada is amongst the biggest sector in the world for pharmaceutical sales, with a 2.1% share. The robust presence of the pharmaceutical industry, with the growing effectiveness of the cluster headache treatment drugs, is expected to surge the market expansion in the region.

The US market dominated the North America Cluster Headache Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $118.9 Million by 2028. The Canada market is poised to grow at a CAGR of 5.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 5.1% during (2022 - 2028).

Based on Distribution channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Type, the market is segmented Episodic, and Chronic. Based on Drug Class, the market is segmented into Triptans, Calcium Channel Blockers, Ergot Derivatives, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grunenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.

Scope of the Study

Market Segments covered in the Report:

By Distribution channel

Drug Stores & Retail Pharmacies
Hospital Pharmacies
Others

By Type

Episodic
Chronic

By Drug Class

Triptans
Calcium Channel Blockers
Ergot Derivatives
Others

By Country

US
Canada
Mexico
Rest of North America

Companies Profiled

Dr. Reddy's Laboratories Ltd.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline PLC (GSK)
Pfizer, Inc.
Fresenius SE & Co. KGaA
Eli Lilly And Company
Grunenthal GmbH
Arrotex Pharmaceuticals Pty Limited

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Cluster Headache Market, by Distribution channel
- 1.4.2 North America Cluster Headache Market, by Type
- 1.4.3 North America Cluster Headache Market, by Drug Class
- 1.4.4 North America Cluster Headache Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. North America Cluster Headache Market by Distribution channel

2.4 North America Drug Stores & Retail Pharmacies Market by Country
2.5 North America Hospital Pharmacies Market by Country
2.6 North America Others Market by Country

Chapter 4. North America Cluster Headache Market by Type

3.1 North America Episodic Market by Country
3.2 North America Chronic Market by Country

Chapter 5. North America Cluster Headache Market by Drug Class

4.1 North America Triptans Market by Country
4.2 North America Calcium Channel Blockers Market by Country
4.3 North America Ergot Derivatives Market by Country
4.4 North America Others Market by Country

Chapter 6. North America Cluster Headache Market by Country

5.1 US Cluster Headache Market
- 5.1.1 US Cluster Headache Market by Distribution channel
- 5.1.2 US Cluster Headache Market by Type
- 5.1.3 US Cluster Headache Market by Drug Class
5.2 Canada Cluster Headache Market
- 5.2.1 Canada Cluster Headache Market by Distribution channel
- 5.2.2 Canada Cluster Headache Market by Type
- 5.2.3 Canada Cluster Headache Market by Drug Class
5.3 Mexico Cluster Headache Market
- 5.3.1 Mexico Cluster Headache Market by Distribution channel
- 5.3.2 Mexico Cluster Headache Market by Type
- 5.3.3 Mexico Cluster Headache Market by Drug Class
5.4 Rest of North America Cluster Headache Market
- 5.4.1 Rest of North America Cluster Headache Market by Distribution channel
- 5.4.2 Rest of North America Cluster Headache Market by Type
- 5.4.3 Rest of North America Cluster Headache Market by Drug Class

Chapter 7. Company Profiles

6.1 Dr. Reddy's Laboratories Ltd.
- 6.1.1 Company Overview
- 6.1.2 Financial Analysis
- 6.1.3 Segmental and Regional Analysis
- 6.1.4 Research & Development Expense
6.2 Novartis AG
- 6.2.1 Company Overview
- 6.2.2 Financial Analysis
- 6.2.3 Segmental and Regional Analysis
- 6.2.4 Research & Development Expense
6.3 Sun Pharmaceutical Industries Ltd.
- 6.3.1 Company Overview
- 6.3.2 Financial Analysis
- 6.3.3 Regional & Segmental Analysis
- 6.3.4 Research & Development Expenses
6.4 Teva Pharmaceutical Industries Ltd.
- 6.4.1 Company Overview
- 6.4.2 Financial Analysis
- 6.4.3 Regional Analysis
- 6.4.4 Research & Development Expenses
6.5 GlaxoSmithKline PLC (GSK)
- 6.5.1 Company Overview
- 6.5.2 Financial Analysis
- 6.5.3 Segmental and Regional Analysis
- 6.5.4 Research & Development Expense
6.6 Pfizer, Inc.
- 6.6.1 Company Overview
- 6.6.2 Financial Analysis
- 6.6.3 Regional & Segmental Analysis
- 6.6.4 Research & Development Expense
6.7 Fresenius SE & Co. KGaA
- 6.7.1 Company Overview
- 6.7.2 Financial Analysis
- 6.7.3 Segmental and Regional Analysis
- 6.7.4 Research & Development Expenses
6.8 Eli Lilly And Company
- 6.8.1 Company Overview
- 6.8.2 Financial Analysis
- 6.8.3 Regional Analysis
- 6.8.4 Research & Development Expenses
6.9 Grunenthal GmbH
- 6.9.1 Company Overview
- 6.9.2 Financial Analysis
- 6.9.3 Segmental and Regional Analysis
- 6.9.4 Research & Development Expenses
7.10. Arrotex Pharmaceuticals Pty Limited
- 6.10.1 Company Overview

LIST OF TABLES

TABLE 1 North America Cluster Headache Market, 2018 - 2021, USD Million
TABLE 2 North America Cluster Headache Market, 2022 - 2028, USD Million
TABLE 3 North America Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 4 North America Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 5 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 12 North America Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 13 North America Episodic Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Episodic Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Chronic Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Chronic Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 18 North America Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 19 North America Triptans Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Triptans Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Ergot Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Ergot Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Cluster Headache Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Cluster Headache Market by Country, 2022 - 2028, USD Million
TABLE 29 US Cluster Headache Market, 2018 - 2021, USD Million
TABLE 30 US Cluster Headache Market, 2022 - 2028, USD Million
TABLE 31 US Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 32 US Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 33 US Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 34 US Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 35 US Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 36 US Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 37 Canada Cluster Headache Market, 2018 - 2021, USD Million
TABLE 38 Canada Cluster Headache Market, 2022 - 2028, USD Million
TABLE 39 Canada Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 40 Canada Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 41 Canada Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 42 Canada Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 43 Canada Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 44 Canada Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 45 Mexico Cluster Headache Market, 2018 - 2021, USD Million
TABLE 46 Mexico Cluster Headache Market, 2022 - 2028, USD Million
TABLE 47 Mexico Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 48 Mexico Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 49 Mexico Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 50 Mexico Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 51 Mexico Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 52 Mexico Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 53 Rest of North America Cluster Headache Market, 2018 - 2021, USD Million
TABLE 54 Rest of North America Cluster Headache Market, 2022 - 2028, USD Million
TABLE 55 Rest of North America Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 56 Rest of North America Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 57 Rest of North America Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 58 Rest of North America Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 59 Rest of North America Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 60 Rest of North America Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 61 key information - Dr. Reddy's Laboratories Ltd.
TABLE 62 Key Information - Novartis AG
TABLE 63 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 64 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 65 Key Information - GlaxoSmithKline PLC (GSK)
TABLE 66 Key Information - Pfizer, Inc.
TABLE 67 key information - Fresenius SE & Co. KGaA
TABLE 68 Key Information - Eli Lilly And Company
TABLE 69 Key Information - Grunenthal GmbH
TABLE 70 Key Information - Arrotex Pharmaceuticals Pty Limited

List of Figures

FIG 1 Methodology for the research

North America Cluster Headache Market Size, Share & Industry Trends Analysis Report By Distribution channel, By Type, By Drug Class, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents